Insider · CIK 0001832432
Valerie Odegard
Files at ODTX (Odyssey Therapeutics, Inc.). First filing -, latest -.
In brief
Valerie Odegard files SEC Form 4 as director at ODTX (Odyssey Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Valerie Odegard has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | ODTX Odyssey Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,393 | $0.00 | $0 | 27,393 | May 11, 2026 |
Questions about Valerie Odegard
Answered from the filings on this page, as of the latest one.
Is Valerie Odegard buying or selling?
Valerie Odegard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Valerie Odegard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Valerie Odegard has 0.
Where does Valerie Odegard file Form 4?
Valerie Odegard has filed Form 4 at ODTX (Odyssey Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.